The allegations read: Clients claim in october 2001 they purchased shares of cepheid and nanogen on the advice of the ir (in [customer's] account) and with the ir's promise he would monitor the stocks and stay in contact with them on a regular basis regarding when to sell the stock. Clients claim sthis was not done and they have incurred a substantial loss as a result. Claim exceeds $5,000
